Standards for radiofrequency ablation (RFA), Second edition

Reference: 
BFCR(13)8
Date: 
2013
Date of next review: 
2016
Status: 
Current

Radiofrequency ablation (RFA) is now an accepted method of local tumour ablation, with published guidelines on its use by the National Institute for Health and Clinical Excellence (NICE), and has been shown to increase survival in appropriately selected patients.

Radiofrequency ablation is a rapidly developing minimally invasive treatment for certain cancers of the lung, liver and kidney. It is also useful in certain bone tumours. Currently, equity of access to this important therapeutic option is poor but many NHS trusts are considering developing services. This standard was written in response to the current demand for guidance. Tumour ablation is a rapidly developing field with cryotherapy, microwave ablation and high intensity ultrasound all beginning to prove their effectiveness. These standards of practice should be applicable to all.